As of 2026-02-10, the Intrinsic Value of Newscope Capital Corporation (PHRM.CN) is -0.45 CAD. This PHRM.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.08 CAD, the upside of Newscope Capital Corporation is -659.59%.
Based on its market price of 0.08 CAD and our intrinsic valuation, Newscope Capital Corporation (PHRM.CN) is overvalued by 659.59%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.45 - -0.45 | -0.45 | -659.59% |
| P/E | (0.01) - (0.11) | (0.01) | -115.7% |
| DDM - Stable | (0.29) - 48.33 | 24.02 | 29926.4% |
| DDM - Multi | (0.15) - 19.75 | (0.31) | -484.2% |
| Market Cap (mil) | 7.08 |
| Beta | 0.07 |
| Outstanding shares (mil) | 88.52 |
| Enterprise Value (mil) | 6.14 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.13% |
| Cost of Debt | 5.00% |
| WACC | 4.91% |